Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study

Paola Guglielmelli, Flavia Biamonte, Giada Rotunno, Valentina Artusi, Lucia Artuso, Isabella Bernardis, Elena Tenedini, Lisa Pieri, Chiara Paoli, Carmela Mannarelli, Rajmonda Fjerza, Elisa Rumi, Viktoriya Stalbovskaya, Matthew Squires, Mario Cazzola, Rossella Manfredini, Claire Harrison, Enrico Tagliafico, Alessandro M Vannucchi, COMFORT-II InvestigatorsH.C. Kluin-Nelemans

    Onderzoeksoutput › Academic › peer review

    116 Citaten (Scopus)

    Vingerafdruk

    Duik in de onderzoeksthema's van 'Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study'. Samen vormen ze een unieke vingerafdruk.

    Pharmacology, Toxicology and Pharmaceutical Science

    Keyphrases

    Biochemistry, Genetics and Molecular Biology